“…dTMP, which, after a sequence of phosphorylation forms dTTP and is uti lized for DNA synthesis, is in turn produced either by de novo synthesis from carbamylasparate or by phosphorylation of exogen ous thymidine by the salvage pathway. The two alternative pathways of thymidylate synthesis, the de novo and the salvage path ways, are interrelated by a common end product, dTTP which exerts a regulatory in fluence on both pathways by a feedback in hibition [17], This also accounts for the re ciprocity of the two pathways [9], In defi ciency of vitamin B12 and folate or in the presence of folate antagonists such as MTX, the impairment of the de novo pathway leads to increased activity of the salvage en zyme, thymidine kinase [16,22], which in turn promotes increased incorporation of exogenous thymidine into DNA. In con trast, the megaloblastoid erythroblasts in ery throleukaemia marrows showed reduced incorporation of exogenous sH-TdR as compared to normal as well as vitamin B12/ folate-deficient megaloblastic bone mar rows.…”